Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sleep Cycle AB ( (SE:SLEEP) ) has shared an announcement.
Sleep Cycle AB reported a slight decline in net sales and operating profit for the second quarter of 2025, with a decrease in the number of paying subscribers. Despite these challenges, the company is expanding its market presence by initiating a clinical trial for AI-based sleep apnea screening and launching collaborations with food delivery services. These strategic moves aim to enhance Sleep Cycle’s industry positioning and tap into new market opportunities.
The most recent analyst rating on (SE:SLEEP) stock is a Hold with a SEK32.00 price target. To see the full list of analyst forecasts on Sleep Cycle AB stock, see the SE:SLEEP Stock Forecast page.
More about Sleep Cycle AB
Sleep Cycle AB operates in the sleep technology industry, offering products and services focused on improving sleep quality. The company is known for its sleep tracking applications and has recently ventured into AI-based sleep apnea screening, targeting a significant market opportunity.
Average Trading Volume: 22,387
Technical Sentiment Signal: Sell
Current Market Cap: SEK588M
Learn more about SLEEP stock on TipRanks’ Stock Analysis page.